FDA Inspection
Cooper Institute for Reproductive Hormonal Disorders, P.C.Cooper Institute for Reproductive Hormonal Disorders, P.C. – FDA Inspection, Apr 1, 2022
Record Details
This FDA Inspection record concerns Cooper Institute for Reproductive Hormonal Disorders, P.C., with an inspection on April 1, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 1, 2022
- Product Type
- Biologics
View Company Profile
ID · e6092cfe-207a-4b22-9a3a-b1733df8bdbf
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1167728
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Cooper Institute for Reproductive Hormonal Disorders, P.C.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 9, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 31, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 10, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 27, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 30, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Cooper Institute for Reproductive Hormonal Disorders, P.C.
- FDA Inspection 1244990 - 2024-07-09
- FDA Inspection 1054887 - 2018-05-31
- FDA Inspection 961504 - 2016-02-10
- FDA Inspection 868830 - 2014-02-27
- FDA Inspection 755731 - 2011-11-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.